Elevance Health, Inc. ELV
Set alert
413.60 USD -6.47 -1.54%
At close · Nov 2
413.60 0.00 0.00%
After hours · Nov 2, 6:48 PM ET
406.90 Day range 424.11
274.84 52-week range 450.69
- YTD
- +17.99%
- 1 year
- +30.39%
- Open
- 421.34
- Prev close
- 420.07
- Mkt cap
- 89.70B
- Vol
- 2.18M
- Avg vol
- 1.16M
- EPS
- 23.55
- P/E
- 17.56
- Div yield
- 1.64%
More statistics
- Low
- 406.90
- High
- 424.11
- Forward P/E
- 13.66
- Beta
- 0.63
- Short ratio
- 4.04
- Inst. own
- 94.68%
- Dividend
- 6.88
- Ex-div date
- Dec 3, 2026
- Earnings
- Jan 27, 2027
- 50-d avg
- 410.56
- 200-d avg
- 372.35
- 1y target
- 482.38
MAX chart
Events in this range
- Jun 1, 2005Split: 2 for 1
- Sep 7, 2011Dividend: 0.25
- Dec 7, 2011Dividend: 0.25
- Mar 7, 2012Dividend: 0.2875
- Jun 6, 2012Dividend: 0.2875
- Sep 6, 2012Dividend: 0.2875
- Dec 5, 2012Dividend: 0.2875
- Mar 6, 2013Dividend: 0.375
- Jun 6, 2013Dividend: 0.375
- Sep 6, 2013Dividend: 0.375
- Dec 5, 2013Dividend: 0.375
- Mar 6, 2014Dividend: 0.4375
- Jun 6, 2014Dividend: 0.4375
- Dec 3, 2014Dividend: 0.4375
- Mar 6, 2015Dividend: 0.625
- Dec 2, 2015Dividend: 0.625
- Sep 7, 2016Dividend: 0.65
- Dec 1, 2016Dividend: 0.65
- Jun 7, 2017Dividend: 0.65
- Sep 7, 2017Dividend: 0.7
- Dec 4, 2017Dividend: 0.7
- Jun 7, 2018Dividend: 0.75
- Sep 7, 2018Dividend: 0.75
- Dec 4, 2018Dividend: 0.75
- Jun 7, 2019Dividend: 0.8
- Dec 4, 2019Dividend: 0.8
- Dec 5, 2019Dividend: 0.8
- Dec 4, 2020Dividend: 0.95
- Dec 2, 2021Dividend: 1.13
- Dec 2, 2022Dividend: 1.28
- Sep 7, 2023Dividend: 1.48
- Dec 5, 2023Dividend: 1.48
- Mar 7, 2024Dividend: 1.63
- Dec 5, 2024Dividend: 1.63
- Dec 5, 2025Dividend: 1.71
Signals (98)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 1, 2026 | 1 month ago |
| MACD: Buy Signal | May 1, 2026 | 6 months ago |
| SMA: Bullish | Apr 1, 2026 | 7 months ago |
| SMA: Bearish | Oct 1, 2024 | 2 years ago |
| MACD: Sell Signal | Oct 1, 2024 | 2 years ago |
| SMA: Bearish | Sep 1, 2024 | 2 years ago |
| MACD: Buy Signal | Apr 1, 2024 | 2 years ago |
| SMA: Bullish | Nov 1, 2023 | 3 years ago |
| SMA: Bullish | Nov 1, 2023 | 3 years ago |
| SMA: Bearish | Aug 1, 2023 | 3 years ago |
| SMA: Bearish | Jan 1, 2023 | 3 years ago |
| MACD: Sell Signal | Jan 1, 2023 | 3 years ago |
| SMA: Bullish | Oct 1, 2022 | 4 years ago |
| MACD: Buy Signal | Oct 1, 2022 | 4 years ago |
| SMA: Bearish | Sep 1, 2022 | 4 years ago |
| MACD: Sell Signal | Sep 1, 2022 | 4 years ago |
| RSI: Overbought | Mar 1, 2022 | 4 years ago |
| RSI: Overbought | Dec 1, 2021 | 4 years ago |
| RSI: Overbought | Oct 1, 2021 | 5 years ago |
| MACD: Buy Signal | Dec 1, 2020 | 5 years ago |
Newest 20 of 98.
Financial health
Altman Z-Score
3.03 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
7 / 9 Strong
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
A-4 / 5 overall
- DCF 5
- Return on Equity 4
- Return on Assets 4
- Debt / Equity 1
- P/E 3
- P/B 3
Valuation
P/E 13.9×
FY 2016 5y median 18.4× FY 2025
P/S 0.4×
FY 2016 5y median 0.6× FY 2025
P/B 1.8×
FY 2016 5y median 2.8× FY 2025
P/FCF 24.5×
FY 2016 5y median 17.0× FY 2025
EV/EBITDA 10.5×
FY 2016 5y median 12.4× FY 2025
EV/Sales 0.5×
FY 2016 5y median 0.8× FY 2025
FCF Yield 4.1%
FY 2016 5y median 5.9% FY 2025
Profitability
Gross Margin 25.6%
FY 2016 5y median 26.0% FY 2025
Operating Margin 4.1%
FY 2016 5y median 5.1% FY 2025
Net Margin 2.8%
FY 2016 5y median 3.5% FY 2025
ROE 12.9%
FY 2016 5y median 15.2% FY 2025
ROIC 6.6%
FY 2016 5y median 7.4% FY 2025
ROA 4.7%
FY 2016 5y median 5.5% FY 2025
Growth (YoY)
Revenue 12.6%
FY 2016 FY 2025
Operating Income -8.7%
FY 2016 FY 2025
EPS (diluted) -2.2%
FY 2016 FY 2025
Free Cash Flow -30.3%
FY 2016 FY 2025
Financial Health
Current Ratio 1.2×
FY 2016 5y median 1.0× FY 2025
Quick Ratio 1.2×
FY 2016 5y median 1.0× FY 2025
Debt / Equity 0.8×
FY 2016 5y median 0.7× FY 2025
Net Debt / EBITDA 2.5×
FY 2016 5y median 2.0× FY 2025
Interest Coverage 5.8×
FY 2016 5y median 8.5× FY 2025
Dividends
Dividend Yield 2.0%
FY 2016 5y median 1.3% FY 2025
Payout Ratio 27.0%
FY 2016 5y median 23.3% FY 2025
Annual · latest fiscal year ends 2025-12-31